Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Mesoblast, Ltd.

Clinical trials sponsored by Mesoblast, Ltd., explained in plain language.

Mesoblast, Ltd. MESO NASDAQ

Regenerative medicine company developing cell-based therapies for inflammatory diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet recruiting 1 Not yet finished but already full! 1

One-Shot stem cell treatment aims to quiet aching backs

Symptom relief Ongoing

This study tests whether a single injection of rexlemestrocel-L (a type of stem cell) combined with hyaluronic acid can reduce chronic low back pain for at least 12 months. It involves 300 adults with moderate to severe pain from a worn spinal disc who haven't improved with stand…

Phase: PHASE3 • Sponsor: Mesoblast, Ltd. • Aim: Symptom relief

Last updated Jun 27, 2026 14:00 UTC